How much does Rozebalamin (methylcobalamin) cost?

Rozebalamin (methylcobalamin) is a drug containing a derivative of vitamin B12 and is primarily used to treat neurological symptoms caused by vitamin B12 deficiency, particularly in patients with amyotrophic lateral sclerosis (ALS ). Its main mechanism of action is to promote the repair and regeneration of nerve cells, improve nerve conduction speed, and relieve nerve damage symptoms related to vitamin B12 deficiency. As a neuroprotective drug, Rozebalamin can help slow the progression of symptoms and improve the quality of life of ALS patients.

Research into the use of Rozebalamin in the treatment of ALS has shown its potential to relieve symptoms, especially in improving patients' muscle control, motor function and neurological health. Compared with conventional neurotrophic drugs, Rozebalamin has higher bioavailability, can be absorbed by patients more effectively and acts directly on the nervous system. Therefore, it is considered as a potential adjunct drug in ALS treatment.

Currently, Rozebalamin has not been officially launched in China, so it needs to be purchased through overseas channels. Since its pharmaceutical manufacturers are mainly located in Japan, the import price of Rozebalamin is relatively expensive. According to market information, the price of Rozebalamin’s original drug is about more than 7,000 yuan per box. This price is usually applicable to foreign patients or patients who need to import it from Japan. It is important to note that drug prices may fluctuate due to changes in exchange rates or changes in supply and demand.

AlthoughRozebalamin’s price is relatively high, its effectiveness in the treatment of certain specific diseases still makes it have a certain demand in the international market. For domestic patients, if they consider using this drug, they should consult a professional doctor for more detailed usage recommendations and medical insurance reimbursement. It should be noted that since this drug has not yet been included in China’s medical insurance coverage, the patient’s medical burden is relatively large, and the comprehensive impact of the cost of the drug and related treatment costs must be taken into consideration when purchasing.

xa0

References:

[1]https://pins.japic.or.jp/pdf/newPINS/00071540.pdf

[2]https://www.eisai.com/news/2024/news202487.html